ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) — LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Firm) at the moment introduced {that a} majority of the unbiased members of LENSAR’s board of administrators granted three newly-hired non-executive staff inventory choices to buy an combination of 1,650 shares of the Firm’s widespread inventory. The choices have been granted as of January 2, 2025, as inducements materials to every worker coming into into employment with the Firm. The choices have been granted in accordance with Nasdaq Itemizing Rule 5635(c)(4).
The choices have an train worth of $8.69 per share, which is the same as the closing worth of the Firm’s widespread inventory on the grant date. The choices vest as to 25% of the entire quantity of the award on the one-year anniversary of the grant date and in thirty-six considerably equal month-to-month installments thereafter, topic to the brand new worker’s continued service with the corporate. Every inventory choice has a 10-year time period. The choices are topic to the phrases and situations of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a inventory choice settlement masking the grant.
About LENSAR
LENSAR is a commercial-stage medical machine firm targeted on designing, creating, and advertising and marketing superior techniques for the remedy of cataracts and the administration of astigmatism as an integral side of the process. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, extremely ergonomic system using an especially quick dual-modality laser and integrating AI into proprietary imaging and software program. ALLY is designed to remodel premium cataract surgical procedure by using LENSAR’s superior robotic applied sciences with the flexibility to carry out the whole process in a sterile working room or in-office surgical suite, delivering operational efficiencies and lowering overhead. ALLY consists of LENSAR’s proprietary Streamline ® software program expertise, which is designed to information surgeons to realize higher outcomes.
| Contacts: | Lee Roth / Cameron Radinovic | |
| Thomas R. Staab, II, CFO | Burns McClellan for LENSAR | |
| ir.contact@lensar.com | lroth@burnsmc.com / cradinovic@burnsmc.com |
Supply: LENSAR, Inc.
